Nuhenz Tabletis indicated in cardio vascular diseases, diabetic retinopathy and diabetic nephropathy. Nuhenz increases transketolase activity, that can in turn decreases the buildup of detrimental glucose metabolites that can lead to advanced glycation end products (AGE), which may lead to diabetic complications. Benfotiamine also prevents diabetic retinopathy. Benfotiamine and alpha-lipoic acid should be considered as first choices among pathogenetically oriented treatments of diabetic neuropathy.
Nuhenz acts as potent antioxidants that reduce number of free radicals
Reduces the risk of complications associated with diabetes
Nuhenz helps to increase the level of hemeoglobin in the body
Helps in the Treatment of megaloblastic anemias due to a deficiency of folic acid
Treatment of anemias of nutritional origin, pregnancy, infancy, or childhood
Directions For Use
Use as directed by the physician.
Read the label carefully before use
Keep out of reach of the children
Store in a cool dry place away from direct sunlight
Use under medical supervision